These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. An update on VEXAS syndrome. Al-Hakim A; Savic S Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591 [TBL] [Abstract][Full Text] [Related]
37. VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis. Pàmies A; Ferràs P; Bellaubí-Pallarés N; Giménez T; Raventós A; Colobran R Rheumatology (Oxford); 2022 Mar; 61(3):e69-e71. PubMed ID: 34668539 [No Abstract] [Full Text] [Related]
38. A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome. Pozdniakova H; Vedire A; Kadakia A; Imburgio S; Bajwa R; Gupta V; Bhatt R; Hossain MA J Med Cases; 2023 Oct; 14(9-10):327-331. PubMed ID: 37868330 [TBL] [Abstract][Full Text] [Related]
39. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis. Muratore F; Marvisi C; Castrignanò P; Nicoli D; Farnetti E; Bonanno O; Longo R; Zaldini P; Galli E; Balanda N; Beck DB; Grayson PC; Pipitone N; Boiardi L; Salvarani C Arthritis Rheumatol; 2022 Apr; 74(4):665-670. PubMed ID: 34611997 [TBL] [Abstract][Full Text] [Related]
40. Comment on: Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome: reply. Tsuchida N; Uchiyama Y; Maeda A; Horita N; Kirino Y; Matsumoto N Rheumatology (Oxford); 2024 Aug; 63(8):e229-e230. PubMed ID: 38059601 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]